Cargando…
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Uveal melanoma (UM) is a rare malignant cancer of the eye, with up to 50% of patients dying from metastasis, for which no effective treatment is available. Due to the rarity of the disease, there is a great need to harness the limited material available from primary tumors and metastases for advance...
Autores principales: | Yin, Jie, Zhao, Gangyin, Kalirai, Helen, Coupland, Sarah E., Jochemsen, Aart G., Forn-Cuní, Gabriel, Wierenga, Annemijn P. A., Jager, Martine J., Snaar-Jagalska, B. Ewa, Groenewoud, Arwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141637/ https://www.ncbi.nlm.nih.gov/pubmed/37111355 http://dx.doi.org/10.3390/ph16040598 |
Ejemplares similares
-
Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target
por: Groenewoud, Arwin, et al.
Publicado: (2023) -
XePhIR: the zebrafish xenograft phenotype interactive repository
por: Groenewoud, A, et al.
Publicado: (2022) -
Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen
por: Glinkina, Kseniya, et al.
Publicado: (2022) -
HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target
por: Souri, Zahra, et al.
Publicado: (2019) -
Embryonic zebrafish xenograft assay of human cancer metastasis
por: Hill, David, et al.
Publicado: (2018)